• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Clarapath Secures $36M to Automate Pathology Labs with AI-Powered Robotics

by Fred Pennic 07/24/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Clarapath and Mayo Clinic Modernize Pathology Labs with Robotics, AI & Automation

What You Should Know: 

– Clarapath, a leading medical robotics company raises $36M in its Series B-1 round led by Northwell Ventures with participation from strategic players like Mayo Clinic and Ochsner Ventures, bringing Clarapath’s total funding to $75M.

– The company is on a mission to modernize and transform pathology labs through automation and robotics.

The Pathology Challenge: Backlog, Labor Shortages, and Manual Processes

Pathology, the microscopic examination of tissues, forms the backbone of disease diagnosis and treatment across various conditions like cancer, autoimmune diseases, and more. In the US alone, over 12 million biopsies are performed annually, creating a substantial workload for pathology labs. Unfortunately, these labs face a multi-pronged crisis:

  • Severe Labor Shortages: Qualified pathologists are in high demand, leading to delays and backlogs in diagnoses.
  • Rising Caseloads: The increasing number of biopsies creates additional strain on already stretched resources.
  • Outdated Processes: Tissue sample preparation remains a manual and time-consuming process.

Clarapath’s Solution: SectionStar™ and Robotics for Efficient Pathology

Clarapath aims to become the first US-based company to address these challenges with a groundbreaking approach – healthcare robotics and automation. Their flagship product, SectionStar™, is poised to revolutionize the way pathology labs operate.

Benefits of automation in pathology labs include:

  • Reduced Backlogs and Faster Diagnoses: Automation can streamline tissue processing, leading to faster turnaround times and improved patient outcomes.
  • Alleviating Labor Shortages: Robotics can take over repetitive tasks, freeing up pathologists’ time for more complex cases.
  • Standardized Workflows: Automation helps to ensure consistent and reliable tissue preparation, minimizing human error.

Investing in the Future

The new funding will fuel Clarapath’s efforts in several key areas:

  • Commercializing SectionStar™: This innovative system automates the sectioning and transfer of tissue samples, significantly improving lab efficiency and consistency.
  • Expanding Sales and Service: Clarapath will extend its reach to equip more labs with its advanced robotic solutions.
  • Enhancing Manufacturing: The company plans to invest in precision manufacturing capabilities to ensure consistent production of its robotic systems.
  • Driving Innovation: Continued research and development will bring forth even more advanced tools to further transform the field of pathology.
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Digital Pathology, Healthcare Robots

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |